AGM/EGM3 Sept 2026, 06:41 pm
Medicamen Biotech Ltd: Annual Report 2025-26 Filed
AI Summary
Medicamen Biotech Ltd has filed its Annual Report for the financial year 2025-26, coinciding with the notice for its 33rd Annual General Meeting (AGM). The AGM will be held on September 26, 2026, via Video Conferencing/Other Audio Visual Means. The report includes the Business Responsibility and Sustainability Report and details the company's strategic progress, including strengthening its oncology division, expanding market presence, and accelerating growth in domestic and international markets. The company has also facilitated remote e-voting for shareholders from September 23 to September 25, 2026.
Key Highlights
- Annual Report for FY 2025-26 filed.
- 33rd AGM scheduled for September 26, 2026, via VC/OAVM.
- Integrated Annual Report includes Business Responsibility and Sustainability Report.
- Remote e-voting facility available from September 23-25, 2026.
- Company highlights growth in oncology, market expansion, and international initiatives.
Price Impact
More from MEDICAMEQ